Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6120)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2019 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774 [PMID: 31011260 DOI: 10.3748/wjg.v25.i14.1764] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm |
| Number | Citing Articles |
| 1 |
Nunzia Capozzi, Ingrid Ordás, Agnès Fernandez-Clotet, Jesús Castro-Poceiro, Sonia Rodríguez, Ignacio Alfaro, Víctor Sapena, Maria Carme Masamunt, Elena Ricart, Julian Panés, Jordi Rimola. Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn’s Disease. Journal of Crohn's and Colitis 2020; 14(8): 1074 doi: 10.1093/ecco-jcc/jjaa030
|
| 2 |
Jordi Rimola, Julian Panés, Ingrid Ordás. Letter: accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease—authors' reply. Alimentary Pharmacology & Therapeutics 2021; 53(1): 207 doi: 10.1111/apt.16163
|
| 3 |
Jordi Rimola, Agnès Fernàndez‐Clotet, Nunzia Capozzi, Sònia Rojas‐Farreras, Ignacio Alfaro, Sonia Rodríguez, Maria‐Carme Masamunt, Elena Ricart, Ingrid Ordás, Julian Panés. Pre‐treatment magnetic resonance enterography findings predict the response to TNF‐alpha inhibitors in Crohn's disease. Alimentary Pharmacology & Therapeutics 2020; 52(10): 1563 doi: 10.1111/apt.16069
|
| 4 |
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese, Subrata Ghosh. Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 2021; 14: 175628482110599 doi: 10.1177/17562848211059954
|
| 5 |
Chunhui Bao, Luyi Wu, Di Wang, Liming Chen, Xiaoming Jin, Yin Shi, Guona Li, Jingzhi Zhang, Xiaoqing Zeng, Jianhua Chen, Huirong Liu, Huangan Wu. Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn's disease: A randomized controlled trial. eClinicalMedicine 2022; 45: 101300 doi: 10.1016/j.eclinm.2022.101300
|
| 6 |
Silvio Danese, Pravin Kamble, Jin Yang, Jean-Gabriel Le Moine, Shahnaz Khan, Emma Hawe, Christian Agboton, Song Wang, Peter M. Irving, Than Than Aye. Systematic Literature Review and Meta-analysis: Real-World Mucosal Healing in Vedolizumab-Treated Patients with Crohn’s Disease. GastroHep 2022; 2022: 1 doi: 10.1155/2022/6975416
|